Human Papillomavirus-Related Cervical Carcinoma

Human Papillomavirus-Related Cervical Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

45 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 29%
Top sponsor: Christian Hinrichs
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04436133	Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)	completed	Phase 2	480	National Vaccine and Serum Institute, ChinaINDUSTRY	1	May 6, 2022	clinicaltrials

Data updated 23 days agoSource updated May 6, 2022source: clinicaltrials